Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Charles Dunlop, Aaron Elliott, Emmanuelle Charpentier, Jennifer Doudna, Feng Zhang, and More

Charles Dunlop and Aaron Elliott

Ambry Genetics has announced that current CEO Charles Dunlop will assume the role of president while retaining his position as chairman of the company's board of directors, and current COO and CSO Aaron Elliott will assume the role of CEO. Dunlop founded the company in 1999 and is stepping down from his role as CEO for personal reasons. He plans to take a very active role in AmbryShare, launched by the company on March 8. Elliott came to Ambry in 2008 and has held numerous executive roles. Prior to joining Ambry, he worked at Novartis developing genomic strategies to profile cancer stem cells.

Canada Gairdner International Award Winners

Rodolphe Barrangou of North Carolina State University; Emmanuelle Charpentier of the Max Planck Institute for Infection Biology, Berlin; Jennifer Doudna of the University of California; Phillippe Horvath of DuPont; and Feng Zhang of the Massachusetts Institute of Technology have been awarded the Canada Gairdner International Award for their work on CRISPR/Cas systems.

The recipients will be presented with the award in a ceremony Oct. 27, 2016, at the Royal Ontario Museum and will each receive C$100,000 (US$75,901).

OpGen Clinical Advisory Board

OpGen has appointed Debra Goff, Dag Harmsen, Stefan Riedel, and Morton Sommer to its clinical advisory board.

Goff is an infectious disease specialist. She has previously served a program director of the Infectious Diseases Residency at the Ohio State University Wexner Medical Center. Goff is also a founding member of the school's Antimicrobial Stewardship Program at the Department of Pharmacy.

Harmsen is a clinical microbiology and infectious disease epidemiology specialist. He has recently earned recognition for the first prospective application of benchtop next-generation sequencing genomics during Germany's E. coli STEC 0104:H4 outbreak in 2011.

Riedel is associate medical director of the Clinical Microbiology Laboratories at Beth Israel Deaconess Medical Center in Boston and is associate professor of pathology at the Harvard Medical School. He is also a member of the College of American Pathologists Microbiology Resource Committee.

Sommer is a professor and associate scientific director at the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark.

For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.